Reinhart K C, Dubey R K, Mummery C L, van Rooijen M, Keller P J, Marinella R
Department of Obstetrics and Gynecology, Clinic for Endocrinology, University Hospital, Zurich, Switzerland.
Mol Hum Reprod. 1998 Mar;4(3):301-8. doi: 10.1093/molehr/4.3.301.
Leukaemia inhibitory factor (LIF) is an essential factor for embryo implantation. Factors generated by the oviduct cells (epithelial cells and fibroblasts) create the microenvironment for fertilization and first embryo stage development. Hence, it is feasible that the oviduct cells also synthesize LIF to promote and condition the embryo for implantation in the uterus. In the present study, we investigated whether cultured bovine oviduct epithelial cells and fibroblasts synthesize LIF. LIF production was measured in the conditioned medium of oviduct epithelial cells and fibroblasts, using LIF enzyme-linked immunosorbent assay. Moreover, expression of LIF mRNA was confirmed by LIF reverse transcriptase-polymerase chain reaction in extracts of RNA from oviduct epithelial/fibroblast cells. Quantitatively similar amounts of LIF were detected in the culture medium of epithelial cells and fibroblasts. In cells cultured for 1-7 days, the levels of LIF in the medium increased in a time-dependent manner. As compared to untreated cells, treatment of cells with 17beta-oestradiol (1-100 ng/ ml), but not progesterone (1-100 ng/ml) and insulin (20 ng/ml), increased the levels of LIF in a concentration-dependent manner (P < 0.05). Similarly, tumour necrosis factor-alpha (100 ng/ml) significantly induced the levels of LIF. The effects of 17beta-oestradiol (50 ng/ml) on LIF synthesis were enhanced and not blocked in the presence of tamoxifen (1 microg/ml), an oestrogen receptor antagonist, suggesting that the stimulatory effects of 17beta-oestradiol on LIF synthesis are not receptor-mediated. In conclusion 17beta-oestradiol, but not progesterone, induces LIF synthesis by bovine oviduct epithelial cells and fibroblasts and this may play an important role in the biology of early embryo development. However, the exact pathophysiological role of LIF within the oviduct needs to be further investigated.
白血病抑制因子(LIF)是胚胎着床的关键因素。输卵管细胞(上皮细胞和成纤维细胞)产生的因子为受精和胚胎早期发育创造了微环境。因此,输卵管细胞也合成LIF以促进胚胎并使其具备在子宫着床的条件是可行的。在本研究中,我们调查了培养的牛输卵管上皮细胞和成纤维细胞是否合成LIF。使用LIF酶联免疫吸附测定法在输卵管上皮细胞和成纤维细胞的条件培养基中测量LIF的产生。此外,通过LIF逆转录聚合酶链反应在输卵管上皮/成纤维细胞的RNA提取物中证实了LIF mRNA的表达。在上皮细胞和成纤维细胞的培养基中检测到数量在定量上相似的LIF。在培养1 - 7天的细胞中,培养基中LIF的水平呈时间依赖性增加。与未处理的细胞相比,用17β - 雌二醇(1 - 100 ng/ml)处理细胞,但用孕酮(1 - 100 ng/ml)和胰岛素(20 ng/ml)处理则不会,以浓度依赖性方式增加了LIF的水平(P < 0.05)。同样,肿瘤坏死因子 - α(100 ng/ml)显著诱导了LIF的水平。在存在雌激素受体拮抗剂他莫昔芬(1 μg/ml)的情况下,17β - 雌二醇(50 ng/ml)对LIF合成的作用增强而不是被阻断,这表明17β - 雌二醇对LIF合成的刺激作用不是受体介导的。总之,17β - 雌二醇而非孕酮诱导牛输卵管上皮细胞和成纤维细胞合成LIF,这可能在早期胚胎发育生物学中起重要作用。然而,LIF在输卵管内的确切病理生理作用需要进一步研究。